Are other issuers delaying offerings because one giant deal crowds them out?
Core argument: Anthropic’s $100 billion offering represents roughly 5% of its implied value, and would consume a meaningful amount of large institutions’ finite new-issue budgets for growth capital.
An unprecedented amount of equity supply is coming to market, much of it in one transaction, and it is increasingly plausible that other issuers are simply getting out of the way. Large institutions have finite new-issue budgets, and a $100 billion Anthropic offering would consume a meaningful amount of available growth capital. It would also dominate investor attention and create funding pressure: investors wanting Anthropic may sell or avoid smaller new issues around the same time. This may explain Oura. It reported that demand for its offering was strong, and yet it postponed it. A well-subscribed IPO being postponed suggests something beyond ordinary weak demand.


